Quando a alta potência aquece o joelho antes de atingir o alvo

Controlled photon penetration, wavelength-selective absorption, duty-cycle thermal management.

A 62-year-old woman arrives at the rehabilitation clinic with a problem that sounds simple but is surprisingly difficult to treat. Her knee hurts every time she climbs stairs. Flexion stops at about 95 degrees. The joint is visibly swollen, and conventional treatment has already consumed months without producing a durable change.

The clinician increases laser output.

The patient immediately feels the warmth.

But the deeper target has not necessarily received the same proportion of useful energy.

This is one of the practical contradictions behind high-intensity laser treatment therapy. The machine may be powerful enough to produce a strong thermal sensation at the skin, while optical scattering and absorption progressively reduce the available photon flux as the beam travels through subcutaneous tissue, fascia, muscle, and the periarticular structures surrounding the knee.

The solution is not simply to turn the power higher.

The solution is to control where the energy is absorbed, how quickly it is delivered, and how much heat the superficial tissue is allowed to accumulate.

That distinction becomes especially important when a clinic is evaluating a deep tissue laser therapy system for chronic knee osteoarthritis, tendon disorders, shoulder pain, or other conditions where the pathological target is several centimeters below the treatment surface.

FotonMedix’s LaserMedix-MAX is designed around this type of high-energy rehabilitation workflow, combining 650 nm, 810 nm, 915 nm, 940 nm, and 980 nm wavelengths with a stated 30 W output, temperature indication, dual hot and cold functions, and a claimed penetration depth of up to 15 cm.

The Real Limitation Is Not the Skin

When clinicians talk about penetration, it is tempting to imagine that a laser simply travels downward until it reaches a particular depth.

Biological tissue does not behave that way.

Every layer changes the optical environment.

Skin contains melanin, blood, and water. Subcutaneous fat changes scattering. Fascia and muscle have their own absorption and scattering characteristics. Blood vessels introduce hemoglobin as an important chromophore. Joint capsules and synovial tissue introduce additional water-rich structures.

The original optical energy therefore declines continuously as the beam travels.

Two processes dominate this decline.

Absorption removes photon energy from the propagating beam by transferring it into tissue chromophores.

Scattering changes the direction of photons, so the energy becomes spatially distributed rather than remaining concentrated along the original optical path.

This means that a treatment head delivering high peak power at the skin does not mean that the same power density exists at the joint capsule.

That is the reason a serious deep tissue laser therapy protocol has to consider the entire optical path.

Why 1470 nm Changes the Treatment Strategy

1470 nm is particularly interesting because water absorbs this wavelength far more strongly than it absorbs many shorter near-infrared wavelengths.

Published optical data show a large difference in water absorption between 980 nm and 1470 nm. One review of near-infrared laser tissue interaction reports a water absorption coefficient of approximately 24.8 cm⁻¹ at 1470 nm compared with approximately 0.45 cm⁻¹ around 975 to 980 nm.

That difference has an immediate practical consequence.

A 1470 nm treatment should not be described simply as a “deeper” wavelength.

Strong water absorption means that energy can be deposited more readily in water-rich tissue, but it also means the optical penetration depth can be shorter.

This is an important technical contradiction.

A wavelength can have stronger tissue interaction while penetrating less deeply.

For a clinician managing synovial swelling or a water-rich inflammatory environment, this can be useful. But it requires controlled dosing because the same absorption characteristic that makes 1470 nm biologically interesting can also increase local thermal accumulation.

This is where power, movement, pulse structure, treatment area, and duty cycle become inseparable from wavelength selection.

Why 980 nm Behaves Differently

At approximately 980 nm, water absorption is substantially lower than at 1470 nm, while hemoglobin absorption remains relevant.

The relationship between these chromophores has been described extensively in medical laser literature. Studies comparing wavelengths used for tissue treatment distinguish shorter near-infrared wavelengths such as 810, 940, 980, and 1064 nm from longer wavelengths above approximately 1200 nm, where water becomes a much more dominant absorber.

This gives 980 nm a different treatment profile.

For a deep rehabilitation protocol, the clinician may use 980 nm when the objective involves deeper optical delivery combined with vascular and photothermal interaction, while using 1470 nm where stronger water absorption is clinically useful.

This is why a multi-wavelength Class IV system can be more practical than a platform built around one fixed wavelength.

The treatment does not have to force every patient into the same optical strategy.

The Case That Exposes the Problem

A manufacturer-published FotonMedix clinical case describes a 62-year-old female patient with bilateral Grade III knee osteoarthritis on the Kellgren-Lawrence scale.

The baseline condition included VAS pain of 8/10, restricted knee flexion at 95 degrees, and visible joint effusion. The case history reported two years of NSAID use and unsuccessful hyaluronic acid injections.

This is exactly the kind of patient who exposes the limitations of a simplistic laser protocol.

The problem is not merely pain at the skin.

The clinician is dealing with a structurally degenerated joint, inflammation, fluid accumulation, restricted movement, and a treatment target located underneath several centimeters of tissue.

Increasing power continuously would create a straightforward problem.

The surface gets hotter faster.

That does not automatically mean the deep joint receives a proportionally higher therapeutic exposure.

The published protocol therefore changed over six weeks rather than keeping one setting throughout the entire course.

Detailed Clinical Case Record

The following table reproduces the treatment progression reported by FotonMedix for this manufacturer-published case. The case identifier shown below is a simulated internal-style department reference for SEO and case organization and is not a hospital record number.

Clinical Item	Informações sobre o caso
Simulated Department Case ID	FM-ORTHO-KOA-026-062
Idade do doente	62 years
Sexo	Feminino
Departamento	Reabilitação ortopédica
Diagnóstico principal	Bilateral Grade III Knee Osteoarthritis
Classificação patológica	Kellgren-Lawrence Grade III
Baseline VAS Pain	8/10
Baseline Knee Flexion	95°
Joint Condition	Visible joint effusion
Relevant Treatment History	Approximately 2 years of NSAID use
Previous Injection Therapy	Hyaluronic acid injections without sustained relief
Treatment Platform	High-intensity dual-wavelength laser system
Treatment Period	6 semanas
Comprimentos de onda primários	980 nm and 1470 nm
Main Treatment Objective	Pain control, edema management, mobility improvement, progressive tissue stimulation

Six-Week Parameter Progression

Semana	980 nm	1470 nm	Potência de pico	Frequência	Ciclo de trabalho	Energia total por sessão	Objetivo clínico
1	80%	20%	15 W	10 Hz	30%	3,000 J	Analgesic phase
2	70%	30%	20 W	20 Hz	35%	4 200 J	Anti-edema phase
3	60%	40%	25 W	50 Hz	40%	5 500 J	Tissue stimulation
4	50%	50%	28 W	100 Hz	50%	7,200 J	Remodeling phase
5	40%	60%	25 W	20 Hz	60%	6,500 J	Matrix repair phase
6	30%	70%	12 W	CW	100%	4,000 J	Soothing and maintenance

The progression is technically more interesting than the maximum power of 28 W.

The clinician increased power during the middle of the treatment course and then reduced it again during the final week.

That is how a practical high-intensity treatment protocol should be understood.

The objective is not to reach maximum power and remain there.

The objective changes as the patient’s clinical state changes.

What Happened During the Six Weeks

At the end of Week 2, the manufacturer case reported a significant reduction in palpable effusion. VAS pain decreased from 8/10 to 5/10, and the patient reported being able to sleep through the night without pain medication.

By Week 4, knee flexion reportedly improved from 95 degrees to 125 degrees. The patient was able to climb stairs without support.

At Week 6, VAS pain was reported at 1/10. Follow-up imaging showed reduced synovial thickening and a more organized synovial fluid appearance, while the patient returned to a low-impact walking program.

These outcomes should not be interpreted as a guarantee for every Grade III osteoarthritis patient.

The case is a manufacturer-published clinical report rather than a randomized controlled trial.

The broader clinical literature is more cautious. A systematic review and meta-analysis of randomized trials found that high-intensity laser therapy can reduce pain and improve stiffness and function in knee osteoarthritis, but the authors also emphasized the limited number and quality of available studies and called for larger, better-designed trials.

That is a much more useful way to present the technology to a professional buyer.

The case demonstrates a treatment strategy.

The clinical literature provides a broader evidence context.

Neither should be turned into a universal promise.

Why the Wavelength Ratio Changed Every Week

The first week used an 80% 980 nm and 20% 1470 nm ratio.

This is not a random combination.

At the beginning of treatment, the clinician has to deal with a painful, reactive joint. A lower total energy and relatively conservative duty cycle allow the operator to establish patient tolerance before progressively increasing the treatment load.

The second week increased the 1470 nm component to 30%.

This matters because 1470 nm has much stronger water absorption.

If the clinical target includes joint effusion or water-rich inflammatory tissue, increasing the contribution of this wavelength changes the distribution of absorbed energy.

The third and fourth weeks moved toward a more balanced combination.

At Week 4, the protocol reached 28 W with a 50% duty cycle and a 50:50 wavelength ratio.

This represents the highest power stage in the published protocol.

The fifth week then shifted further toward 1470 nm while reducing peak power to 25 W.

The sixth week used only 12 W but a 70% 1470 nm ratio in continuous-wave operation.

The sequence demonstrates an important principle.

Power and wavelength ratio should not be treated as independent settings.

Changing one changes the thermal and optical environment created by the other.

Why Continuous Wave Can Be Appropriate at the End

At first glance, a 100% duty cycle may appear to contradict the idea of thermal management.

It does not necessarily.

Thermal risk depends on much more than duty cycle.

At Week 6, the published protocol reduced peak power to 12 W while using continuous-wave delivery. That is a very different thermal situation from applying 28 W continuously.

The average energy delivery rate is lower.

The tissue is also no longer being exposed to the same treatment objective as during the higher-energy middle phase.

This is an important lesson for anyone comparing a class 4 laser therapy machine for sale.

A machine capable of 30 W or 38 W does not need to operate at its maximum output during every treatment.

The value of the higher output is that the operator has a broader working range.

Duty Cycle Is a Thermal Control Tool

Duty cycle becomes especially important when the treatment head is close to sensitive superficial tissue.

Suppose a clinician applies high peak power continuously to one relatively small region.

The surface temperature can rise rapidly.

The patient complains.

The clinician stops.

The treatment session ends before enough energy has been delivered to the deeper target.

This is an efficiency problem.

Pulsed delivery changes the time structure.

The system can reach a high instantaneous output during the emission phase while allowing intervals for partial thermal dissipation during the off phase.

The average thermal load can therefore be lower than the peak optical output might suggest.

FotonMedix’s veterinary and equine systems make this concept explicit. VetMedix-MAX lists 38 W peak power, Super Pulse operation, adjustable thermal sensation, and temperature indication.

Theralux-Max lists Super Pulse, Pulse, and CW modes, with the company describing pulsed emission as a way to reduce overheating while continuous emission is positioned for large animals or situations requiring high energy over a short period.

The same physical principle matters in human rehabilitation.

Photon Attenuation Creates a Treatment Efficiency Problem

Imagine a treatment target located 5 cm below the skin.

The operator cannot simply assume that the target receives the same optical energy displayed by the machine.

The beam has already encountered:

1. Skin absorption
2. Dermal scattering
3. Subcutaneous scattering
4. Blood absorption
5. Fascial scattering
6. Muscle absorption
7. Additional scattering from deeper structures

The deeper target therefore sees a transformed optical field.

This is why “penetration depth” should be treated carefully in commercial specifications.

A stated 15 cm penetration capability does not mean that 15 cm below the skin receives the same energy density as the surface.

It means the system is designed to maintain useful treatment reach into deeper tissue.

For a B2B buyer, that distinction is important.

It prevents the machine from being evaluated using an unrealistic interpretation of penetration depth.

Why 30 W Is Not the Same as 30 W in Every Machine

A procurement manager may compare two machines.

Machine A claims 30 W.

Machine B claims 30 W.

On paper they appear identical.

In practice they may be very different.

The buyer should ask:

Can the system control wavelength selection?

Can it combine wavelengths?

Can it vary pulse frequency?

Can it adjust duty cycle?

Can the operator monitor treatment temperature?

Can the handpiece be used for broad scanning?

Can the machine maintain treatment output as the operator changes treatment modes?

Can the treatment protocol be reproduced consistently?

LaserMedix-MAX lists five wavelengths, 30 W output, peak penetration depth maintaining technology, temperature indication, and dual hot and cold functions.

These functions influence the clinical workflow much more than a single maximum-power number.

Why a Multi-Wavelength Platform Is Valuable for Clinics

A clinic rarely treats one condition.

The same rehabilitation department may see:

• Osteoartrite do joelho
• Rotator cuff disorders
• Cotovelo de ténis
• Achilles tendon pain
• Fasceíte plantar
• Chronic lumbar pain
• Lesões desportivas
• Muscle strain
• Postoperative rehabilitation
• Dor neuropática

The optical target changes from case to case.

A tendon is not a joint capsule.

A muscle is not a synovial cavity.

A superficial wound is not the same target as a deep hip structure.

That is why a multi-wavelength platform can make more sense commercially than a machine optimized for one treatment scenario.

The LaserMedix-MAX configuration combines five wavelengths from 650 nm through 980 nm and is marketed for pain relief, inflammation management, circulation, tissue repair, wound healing, and motor-function improvement.

The operator can therefore build different protocols rather than purchasing a machine that fits only one department’s treatment style.

The Same Engineering Principle Extends Into Veterinary Medicine

The clinical logic becomes even more obvious when the target animal is larger.

A deep joint in a large dog or horse may be separated from the skin by substantially more tissue than a superficial human treatment target.

VetMedix-MAX uses the same five-wavelength family of 650 nm, 810 nm, 915 nm, 940 nm, and 980 nm while increasing peak output to 38 W. The platform also includes Super Pulse, thermal indication, dual hot and cold functions, and a claimed 15 cm penetration depth.

The equine Theralux-Max similarly uses five wavelengths and 38 W peak power, with separate Super Pulse, Pulse, and CW modes. The manufacturer positions it for muscle, bone, fascia, joint injuries, pain, fatigue recovery, and microtrauma prevention and repair.

This is useful for distributors because it shows that high-intensity laser technology can be configured around different clinical environments without changing the underlying treatment logic.

The Surgical 1470 nm Platform Shows the Other Side of the Same Physics

FotonMedix’s SurgMedix-MAX uses 1470 nm at up to 20 W, 980 nm at up to 40 W, and 635 nm at 0.5 W. The system is positioned for surgical applications including EVLT, proctology, urology, gynecology, arthroscopy, neurology, ENT, LITT, dermatology, dentistry, and general surgery.

This is not the same clinical application as non-invasive rehabilitation.

The distinction matters.

In surgery, the clinician intentionally uses wavelength-dependent tissue absorption to achieve cutting, coagulation, evaporation, or excision.

In rehabilitation, the goal is different.

The operator is trying to deliver high-energy optical stimulation without producing uncontrolled tissue injury.

The same wavelength physics can therefore produce very different clinical outcomes depending on power, exposure time, treatment geometry, tissue contact, and delivery method.

This is exactly why B2B buyers should not compare therapeutic and surgical laser systems purely by wavelength.

What the Research Says About High-Intensity Laser Therapy

The broader evidence base supports cautious optimism rather than exaggerated claims.

A 2020 systematic review and meta-analysis of randomized controlled trials in knee osteoarthritis included six trials and found that high-intensity laser therapy significantly reduced pain compared with controls, with improvements also reported for stiffness and function. The authors nevertheless concluded that larger and better-designed randomized studies were still needed.

A 2022 systematic review and network meta-analysis examined HILT against other physical therapy modalities in knee osteoarthritis. It found HILT ranked favorably for pain and self-reported function, while the improvement in stiffness was statistically significant but smaller than the minimal clinically important difference.

A later systematic review with meta-analysis published in Fisioterapia also examined photobiomodulation for knee osteoarthritis and highlighted the importance of separating statistically significant changes from effects that are clinically meaningful to the patient.

That distinction is critical for medical marketing.

A reduction in pain score is useful.

An increase in knee flexion is useful.

Being able to climb stairs without support is more meaningful.

Returning to walking is more meaningful.

Returning to work or sport is even more meaningful.

A professional laser treatment therapy program should therefore measure functional outcomes, not only whether the patient reports feeling warm.

What the Patient Actually Experiences

The technical discussion eventually comes back to something very ordinary.

The patient wants to know whether the knee will hurt less.

She wants to bend it further.

She wants to climb stairs.

She wants to sleep without waking because of pain.

She wants to walk without planning every movement around the painful joint.

The machine does not achieve those outcomes simply because it has a high wattage rating.

The treatment must be delivered in a way that the patient can tolerate repeatedly.

That is why thermal sensation is not an incidental detail.

If the treatment becomes uncomfortably hot after two minutes, the clinician has to reduce the exposure.

If the patient can tolerate a controlled warming sensation while the handpiece is moved across the treatment area, a longer and more consistent protocol becomes possible.

Temperature indication therefore has practical value.

LaserMedix-MAX specifically lists Therapeutic Temperature Indication Technology among its features.

Why Traditional Treatment Still Has a Place

High-intensity laser should not be marketed as a replacement for every conventional treatment.

A patient with severe structural osteoarthritis still requires orthopedic assessment.

A tendon rupture still requires appropriate diagnostic imaging and clinical management.

A neurological disorder still requires neurological evaluation.

Exercise remains important.

Strengthening remains important.

Mobility training remains important.

Weight management may be important.

Medication may be appropriate.

Surgery may still be necessary in advanced cases.

The practical role of laser is different.

It can become an additional physical modality within the rehabilitation pathway.

If pain limits exercise, the clinician may use laser as part of a strategy intended to improve treatment tolerance.

If swelling restricts movement, the protocol may prioritize a different wavelength balance.

If the patient is progressing into functional rehabilitation, the clinician can modify the treatment load rather than maintaining the initial settings.

That is where laser becomes useful in real clinical workflow.

What Buyers Should Look For in a Class 4 Laser Therapy Machine for Sale

A serious B2B purchasing decision should begin with clinical requirements.

Seleção do comprimento de onda

Ask which wavelengths are available and what optical interaction each wavelength is intended to provide.

Gama de potência

Do not focus only on maximum output.

A broad and controllable operating range is more useful than a machine that is effectively locked into one high-output mode.

Pulse Control

Check available frequencies and whether pulsed operation can be adjusted to the treatment objective.

Ciclo de trabalho

A system should allow the clinician to control emission time relative to rest time when thermal management is important.

Temperature Monitoring

A visible temperature reference can help standardize treatment and improve patient comfort.

Área de tratamento

A deep tissue protocol for the knee is different from a small tendon lesion.

Handpiece geometry and scanning technique therefore matter.

Treatment Reproducibility

The clinician should be able to save or reproduce treatment settings instead of relying entirely on memory.

Department Versatility

For a clinic or distributor, a platform that can serve multiple musculoskeletal indications is generally more commercially useful than a machine built around one narrow application.

The Main Lesson From This Case

The 62-year-old knee case demonstrates a point that is often lost in product marketing.

The treatment did not improve because the clinician simply used the highest available power.

The protocol moved from 15 W in Week 1 to 28 W in Week 4 and then dropped to 12 W in Week 6.

The wavelength balance changed from 80% 980 nm and 20% 1470 nm to 30% 980 nm and 70% 1470 nm.

The duty cycle moved from 30% to 60%, followed by continuous-wave treatment at a much lower power.

The total energy changed from 3,000 J to 7,200 J and then fell to 4,000 J.

Every parameter was part of the treatment strategy.

That is the real difference between operating a high-intensity laser and simply operating a powerful light source.

Final Clinical Perspective

The difficult part of deep tissue laser therapy is not generating heat.

The difficult part is controlling the relationship between optical penetration, tissue absorption, surface temperature, total energy, and biological response.

1470 nm provides strong interaction with water-rich tissue, which can be useful but also requires careful thermal control.

980 nm has a different absorption profile and can provide a useful combination of deeper delivery and interaction with blood-related chromophores.

High peak power provides treatment headroom when photons are lost through scattering and absorption.

Pulse frequency and duty cycle allow that energy to be delivered over time rather than forcing the entire treatment into continuous heating.

Temperature monitoring gives the clinician a practical reference during treatment.

And most importantly, the protocol can change as the patient changes.

That is why a modern laser treatment therapy system should be judged by more than its maximum wattage.

The published six-week case of a 62-year-old woman with Grade III bilateral knee osteoarthritis reported a reduction in VAS pain from 8/10 to 1/10, an improvement in knee flexion from 95° to 125°, improved stair climbing, reduced synovial thickening, and a return to low-impact walking. Those results belong to one manufacturer-published case and should not be treated as a universal outcome, but the treatment progression provides a useful example of how wavelength, power, frequency, duty cycle, and total energy can be deliberately changed throughout a rehabilitation course.

For a clinic evaluating a máquina de terapia laser classe 4 para venda, the most important question is therefore not “How powerful is it?”

A better question is:

Can the system give the clinician enough control to deliver the right amount of energy to the right tissue at the right stage of treatment without making superficial heat the limiting factor?

That is where high-intensity laser becomes clinically interesting.

Traditional passive modalities can provide useful symptom management, but they do not give the clinician the same combination of wavelength selection, temporal control, power adjustment, and cumulative optical energy.

A properly planned Class IV protocol does not replace rehabilitation.

It gives rehabilitation another tool.

And when the clinical problem is deep, persistent, and difficult to reach without excessive surface heating, that additional control can make a meaningful difference to how the treatment is delivered.